Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 6
1953 4
1954 4
1955 5
1956 2
1957 2
1958 8
1959 2
1960 3
1961 5
1962 3
1963 8
1964 6
1965 4
1966 6
1967 3
1968 3
1969 6
1970 4
1971 8
1972 10
1973 1
1974 7
1975 5
1976 8
1977 4
1978 4
1979 3
1980 8
1981 14
1982 9
1983 8
1984 7
1985 12
1986 18
1987 12
1988 10
1989 13
1990 12
1991 11
1992 19
1993 8
1994 7
1995 15
1996 10
1997 10
1998 8
1999 5
2000 6
2001 4
2002 6
2003 4
2004 3
2005 4
2006 6
2007 10
2008 10
2009 6
2010 10
2011 7
2012 10
2013 5
2014 6
2015 9
2016 11
2017 13
2018 14
2019 12
2020 10
2021 13
2022 9
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

532 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, Fabbiano F, Erba HP, Di Stasi A, Stuart R, Olin R, Kasner M, Ciceri F, Chou WC, Podoltsev N, Recher C, Yokoyama H, Hosono N, Yoon SS, Lee JH, Pardee T, Fathi AT, Liu C, Hasabou N, Liu X, Bahceci E, Levis MJ. Perl AE, et al. Among authors: berman e. N Engl J Med. 2019 Oct 31;381(18):1728-1740. doi: 10.1056/NEJMoa1902688. N Engl J Med. 2019. PMID: 31665578 Clinical Trial.
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Deininger MW, Shah NP, Altman JK, Berman E, Bhatia R, Bhatnagar B, DeAngelo DJ, Gotlib J, Hobbs G, Maness L, Mead M, Metheny L, Mohan S, Moore JO, Naqvi K, Oehler V, Pallera AM, Patnaik M, Pratz K, Pusic I, Rose MG, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H. Deininger MW, et al. Among authors: berman e. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1385-1415. doi: 10.6004/jnccn.2020.0047. J Natl Compr Canc Netw. 2020. PMID: 33022644
Letter.
Heru AM M D, Berman E M D, Sargent J M D. Heru AM M D, et al. Among authors: berman e m d. Psychiatr Serv. 2010 May;61(5):531-532. doi: 10.1176/ps.2010.61.5.531. Psychiatr Serv. 2010. PMID: 26649501 No abstract available.
CML and the WHO: Why?
Berman E, Shah NP, Deninger M, Altman JK, Amaya M, Begna K, Bhatia R, Chan O, Collins R, Curtin P, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore J, Oehler V, Pratz K, Pusic I, Rose M, Shomali W, Smith BD, Styler M, Sweet K, Talpaz M, Tanaka T, Tantravahi S, Tsai S, Vaughn J, Welborn J, Yang D, Mauro M, Cortes J, Radich J, Druker B. Berman E, et al. J Clin Oncol. 2024 Mar 20;42(9):984-986. doi: 10.1200/JCO.23.01689. Epub 2023 Dec 12. J Clin Oncol. 2024. PMID: 38086008 No abstract available.
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Adegbite BO, Abramson MH, Gutgarts V, Musteata FM, Chauhan K, Muwonge AN, Meliambro KA, Salvatore SP, El Ghaity-Beckley S, Kremyanskaya M, Marcellino B, Mascarenhas JO, Campbell KN, Chan L, Coca SG, Berman EM, Jaimes EA, Azeloglu EU. Adegbite BO, et al. Among authors: berman em. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1175-1185. doi: 10.2215/CJN.0000000000000219. Epub 2023 Jun 29. Clin J Am Soc Nephrol. 2023. PMID: 37382967
Akinetopsia: A Systematic Review.
Van Swol JM, Thompson EB, Joffe JA, Nguyen SA, Berman EL. Van Swol JM, et al. Among authors: berman el. J Neuroophthalmol. 2023 Nov 3. doi: 10.1097/WNO.0000000000002032. Online ahead of print. J Neuroophthalmol. 2023. PMID: 37938052
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
McCarter JGW, Nemirovsky D, Famulare CA, Farnoud N, Mohanty AS, Stone-Molloy ZS, Chervin J, Ball BJ, Epstein-Peterson ZD, Arcila ME, Stonestrom AJ, Dunbar A, Cai SF, Glass JL, Geyer MB, Rampal RK, Berman E, Abdel-Wahab OI, Stein EM, Tallman MS, Levine RL, Goldberg AD, Papaemmanuil E, Zhang Y, Roshal M, Derkach A, Xiao W. McCarter JGW, et al. Among authors: berman e. Blood Adv. 2023 Sep 12;7(17):5000-5013. doi: 10.1182/bloodadvances.2023009675. Blood Adv. 2023. PMID: 37142255 Free PMC article.
Berman and Johnson Respond.
Berman ER, Johnson RK. Berman ER, et al. Am J Public Health. 2016 Jul;106(7):e9-e10. doi: 10.2105/AJPH.2016.303247. Am J Public Health. 2016. PMID: 27285275 Free PMC article. No abstract available.
532 results